The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth. (2018)

First Author: Hanson K
Attributed to:  Regulation of Neural Crest development by transcriptional pausing funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.23378

PubMed Identifier: 29423085

Publication URI: http://europepmc.org/abstract/MED/29423085

Type: Journal Article/Review

Volume: 9

Parent Publication: Oncotarget

Issue: 3

ISSN: 1949-2553